Literature DB >> 20586192

[Generation of transgenic animals, expressing alpha- and beta-chains of autoreactive TCR].

E S Zvezdova, Iu Iu Silaeva, M S Vagida, E V Mariukhnich, A V Deĭkin, T G Ermolkevich, S G Kadulin, E R Sadchikova, I L Gol'dman, D B Kazanskiĭ.   

Abstract

Transgenic animal studies has become a key approach for gene function analysis as well as for modeling of different human diseases, including autoimmune diseases caused by activation of T-lymphocyte clones whose TCRs possesses high affinity for syngeneic MHC molecules. In this study we cloned genes, encoding alpha- and beta- chains of autoreactive TCR of hybridoma 7, specific for syngeneic MHC class II molecules A(b). Amplified DNA fragments, containing rearranged genomic DNA of alpha- and beta-chains of hybridoma 7 were cloned into special cassette vectors, containing natural promoter and enhancer elements for direct expression of genes encoding TCR alpha- and beta-chains in T-lymphocytes of transgenic animals. Using this cassette vectors we generated animals in which most of peripheral T-lymphocytes carry alpha-chain, as well as animals with expression of beta-chain transgene of autoreactive TCR. Obtained animals may serve to explain a number of intrathymic selection processing features and T cell maturation as well as to serve as experimental models for development of new approaches to therapy of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20586192

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  2 in total

1.  Transcription termination sequences support the expression of transgene product secreted with milk.

Authors:  Alexey Deykin; Maxim Tikhonov; Vladislav Kalmykov; Igor Korobko; Pavel Georgiev; Oksana Maksimenko
Journal:  Transgenic Res       Date:  2019-03-28       Impact factor: 2.788

2.  Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis.

Authors:  Alexandra V Bruter; Diana S Korshunova; Marina V Kubekina; Petr V Sergiev; Anastasiia A Kalinina; Leonid A Ilchuk; Yuliya Yu Silaeva; Eugenii N Korshunov; Vladislav O Soldatov; Alexey V Deykin
Journal:  Transgenic Res       Date:  2021-04-14       Impact factor: 2.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.